UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
UBS Group
UBS
|
+$694M |
| 2 |
Broadcom
AVGO
|
+$567M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$525M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$504M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$351M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$542M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$393M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$370M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$290M |
| 5 |
Fidelity National Information Services
FIS
|
+$264M |
Sector Composition
| 1 | Technology | 17.64% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 8.06% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Syndax Pharmaceuticals
SNDX
$1.3B
| $6.28M | ﹤0.01% |
290,801
+215,444
| +286% | +$4.66M |
|
|
EOS
1802
Eaton Vance Enhance Equity Income Fund II
EOS
$1.29B
| $6.28M | ﹤0.01% |
335,660
+5,242
| +2% | +$98.1K |
|
1803
Celldex Therapeutics
CLDX
$1.63B
| $6.27M | ﹤0.01% |
158,092
+136,897
| +646% | +$5.43M |
|
|
BNRE.A
1804
DELISTED
Brookfield Reinsurance Ltd. Class A-1 Exchangeable Non-Voting Shares
BNRE.A
| $6.27M | ﹤0.01% |
+156,745
| New | +$6.27M |
|
1805
Repligen
RGEN
$6.74B
| $6.26M | ﹤0.01% |
34,831
+5,311
| +18% | +$955K |
|
1806
GATX Corp
GATX
$6B
| $6.25M | ﹤0.01% |
51,988
+21,977
| +73% | +$2.64M |
|
|
BSMO
1807
DELISTED
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
| $6.25M | ﹤0.01% |
250,655
+14,255
| +6% | +$355K |
|
1808
Denali Therapeutics
DNLI
$1.94B
| $6.24M | ﹤0.01% |
290,985
+181,289
| +165% | +$3.89M |
|
1809
TopBuild
BLD
$11.7B
| $6.23M | ﹤0.01% |
16,659
+47
| +0.3% | +$17.6K |
|
1810
iShares MSCI Global Gold Miners ETF
RING
$2.09B
| $6.23M | ﹤0.01% |
253,366
+174,012
| +219% | +$4.28M |
|
1811
Akero Therapeutics
AKRO
$3.41B
| $6.22M | ﹤0.01% |
266,386
+207,983
| +356% | +$4.86M |
|
1812
Applovin
APP
$204B
| $6.22M | ﹤0.01% |
155,964
-41,835
| -21% | -$1.67M |
|
1813
Nuveen ESG Emerging Markets Equity ETF
NUEM
$320M
| $6.2M | ﹤0.01% |
230,047
-26,264
| -10% | -$708K |
|
1814
Pliant Therapeutics
PLRX
$93.9M
| $6.2M | ﹤0.01% |
342,173
+71,369
| +26% | +$1.29M |
|
1815
Medifast
MED
$158M
| $6.19M | ﹤0.01% |
92,044
+16,260
| +21% | +$1.09M |
|
1816
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$846M
| $6.18M | ﹤0.01% |
141,504
-20,908
| -13% | -$914K |
|
1817
Commault Systems
CVLT
$8.43B
| $6.18M | ﹤0.01% |
77,424
+32,217
| +71% | +$2.57M |
|
1818
Sealed Air
SEE
$4.98B
| $6.18M | ﹤0.01% |
169,270
+25,643
| +18% | +$936K |
|
1819
SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$930M
| $6.17M | ﹤0.01% |
259,218
+4,932
| +2% | +$117K |
|
1820
Texas Roadhouse
TXRH
$11B
| $6.17M | ﹤0.01% |
50,447
-8,147
| -14% | -$996K |
|
1821
Haemonetics
HAE
$2.46B
| $6.16M | ﹤0.01% |
72,087
+27,618
| +62% | +$2.36M |
|
1822
The RMR Group
RMR
$292M
| $6.16M | ﹤0.01% |
218,180
+4,282
| +2% | +$121K |
|
1823
Insperity
NSP
$1.95B
| $6.15M | ﹤0.01% |
52,467
-7,736
| -13% | -$907K |
|
1824
SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.43B
| $6.15M | ﹤0.01% |
81,253
+17,370
| +27% | +$1.31M |
|
1825
Sociedad Química y Minera de Chile
SQM
$12.5B
| $6.15M | ﹤0.01% |
102,057
-111,103
| -52% | -$6.69M |
|